Respiratory Infections

An accredited dentist suggests that practiced care for the mouth and teeth could potentially help individuals during flu season.

The broad-spectrum investigational antibiotic has been developed for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

The Cystic Fibrosis Foundation has awarded Motif Bio with $120,000 that will fund in vitro testing for the development of iclaprim to benefit patients with cystic fibrosis who have lung infections.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The World Health Organization (WHO) released its first report on antibiotic resistance surveillance data.

Findings from a new National Institutes of Health study may have important implications for flu vaccine development.

Historically, postoperative pulmonary complications have been the most common serious adverse event following upper abdominal surgery, with incidence rates ranging from 10% to 50%.

As this season’s flu continues to drive patients to hospitals in droves, an IV bag shortage and tapped out staffing makes infection control particularly difficult.

As flu cases continue to rapidly increase this season, school districts around the country have taken to closing schools in order to prevent the spread of the virus.

Whole genome sequencing proved useful in identifying patients with multidrug-resistant tuberculosis in an outbreak among African refugees in Europe.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Marin H. Kollef, MD, discusses Pseudomonas aeruginosa infections within the intensive care unit.

As 49 states report widespread flu activity for the second week in a row, researchers at UCLA offer hope in the form of a new flu vaccine candidate.

William Schaffner, MD, explains what we can expect for the 2017-2018 flu season and how clinicians can ensure their patients get vaccinated.

A new data analysis suggests that individuals born at the time of a flu pandemic are more susceptible to death in future pandemics.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A recent study from the Lovelace Respiratory Research Institute shows that human adenovirus type 4 may be an underestimated cause of acute respiratory disease among adults.

New research suggests that the main mode of transmission during Europe’s Second Pandemic of plague may have been human fleas and lice.

The Centers of Disease Control and Prevention (CDC) held a recent briefing on flu season as 49 states report widespread flu activity.

A new study challenges common misconceptions associated with cases of non-ventilator hospital-acquired pneumonia, emphasizing the need for a broader use of preventive measures.

A FDA committee decided against recommending approval for Linhaliq to treat NCFBE patients with chronic lung Pseudomonas aeruginosa infections.

GlaxoSmithKline has announced that the FDA's Center for Biologics Evaluation and Research has approved expanding the indication for their influenza vaccine to include use in those 6 months of age and older.

Said to have killed more people in a single year than the infamous 14th century European Black Death, the pandemic infected a full third of the world’s population.

Rates of re-hospitalization and long-term health effects remain high among sepsis survivors, which is why researchers are outlining ways to help sepsis patients after hospital discharge.

A pharmacist cuts through the noise surrounding Oscillococcinum and its alleged role in flu management.